Status:

UNKNOWN

Comparative Study Between Only Vaginal Misoprostol and Vaginal Misoprostol and Estradiol Cream

Lead Sponsor:

Ain Shams University

Conditions:

Cervix; Pregnancy

Eligibility:

FEMALE

20-39 years

Phase:

PHASE1

PHASE2

Brief Summary

To compare the safety and effectiveness of vaginal misoprostol with combined vaginal misoprostol and estradiol for induction of labour in unfavorable cervix

Detailed Description

Induction of labour (IOL) is the process of initiating contractions of pregnant persons who are currently not in labour, to help them achieve vaginal delivery within 24 to 48 hours. Cervical ripening ...

Eligibility Criteria

Inclusion

  • Gestational age36:41 weeks.
  • Singleton pregnancy.
  • Absence of labour pain.
  • Living fetus with cephalic presentation.
  • Fetal weight \< 4 k.gs.
  • No previous uterine surgical procedures.
  • No liquor abnormalities.
  • Bishop score \< 5.

Exclusion

  • \- Multiple gestations. one of the contraindications of induction of labor as it may cause rupture of the uterus.
  • Liquor abnormalities.one of contraindications of induction of labor as it may cause fetal distress.
  • Abnormal umbilical artery Doppler indices or non-stress test as these indicate fetal distress.
  • Fetal weight \> 4 kgs.as macrosomia is an indication of caesarean section for fear of shoulder dystocia .
  • Previous uterine surgery.contraindication of labor induction for fear of rupture uterus.
  • Asthmatic patient or women with allergy to prostaglandins or steroidal.
  • Non-vertex presentation.contraindication of labor induction as it may cause rupture uterus.
  • Fetal or maternal complications that might cause cesarean section.
  • Intrauterine fetal death.often induction of labor in women with a dead fetus is performed before term when the uterus may be less responsive to uterotonics than it is at term and this will affect the results of the study

Key Trial Info

Start Date :

February 20 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 30 2022

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT05306405

Start Date

February 20 2022

End Date

August 30 2022

Last Update

April 1 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ain Shams University

Cairo, Egypt